Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Drugs

Issue 4/2022

Content (11 Articles)

Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent Pain

Marco Sisignano, Philip Gribbon, Gerd Geisslinger

Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction

Julie K. K. Vishram-Nielsen, Daniela Tomasoni, Finn Gustafsson, Marco Metra

Antimicrobial Treatment Options for Difficult-to-Treat Resistant Gram-Negative Bacteria Causing Cystitis, Pyelonephritis, and Prostatitis: A Narrative Review

Andrew Chou, Elwyn Welch, Andrew Hunter, Barbara W. Trautner

First-line Immune Checkpoint Inhibitor Combinations in Metastatic Renal Cell Carcinoma: Where Are We Going, Where Have We Been?

Jacob J. Adashek, Joshua J. Breunig, Edwin Posadas, Neil A. Bhowmick, Leigh Ellis, Stephen J. Freedland, Hyung Kim, Robert Figlin, Jun Gong

Molnupiravir: First Approval

Yahiya Y. Syed

Tezepelumab: First Approval

Sheridan M. Hoy

Olverembatinib: First Approval

Sohita Dhillon

Sotrovimab: First Approval

Young-A Heo

Comment on: “Managing Diabetic Foot Ulcers: Pharmacotherapy for Wound Healing”

Bayram Colak, Atilla Orhan, Ilhan Ece, Serdar Yormaz, Huseyin Yilmaz, Mustafa Sahin

Authors’ Reply to Colak et al.: “Managing Diabetic Foot Ulcers: Pharmacotherapy for Wound Healing”

Danielle Dixon, Michael Edmonds

Correction to: Pharmacological Approaches to Managing Violence and Aggression in Prison Populations: Clinical and Ethical Issues

  • Open Access
  • Correction

Michael Weightman, Ranjit Kini, Robert Parker, Mrigendra Das

Feb 22
Issue: 3/2022
Apr 22
Issue: 6/2022

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images